Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Vascutek Custom Fenestrated Anaconda Post-Market Surveillance Study

This study has been terminated.
Information provided by (Responsible Party):
Vascutek Ltd. Identifier:
First received: April 3, 2013
Last updated: December 8, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2015
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)